Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Zippe

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Urology|June 24, 1999
Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA statS Sharma, C D Zippe, L Pandrangi, et al.
BJU International|June 8, 2004
Bupivacaine provides rapid, effective periprostatic anaesthesia for transrectal prostate biopsyJ C Rabets, J S Jones, A R Patel, et al.
The Annals of Pharmacotherapy|January 7, 1998
Comment: clinical experiences of visual disturbances with nilutamideG A Dijkman, L H Klotz, A C Diokno, et al.
Urology|November 24, 1999
Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year resultsF M Jhaveri, C D Zippe, E A Klein, et al.
Urology|August 12, 1999
Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancerS Kedia, C D Zippe, A Agarwal, et al.
Urology|December 4, 1998
Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)C D Zippe, A W Kedia, K Kedia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cellsY Zhang, C D Zippe, F Van Lente, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?D Keyser, P A Kupelian, C D Zippe, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2004
Variable definitions influence the reporting of biochemical failure ratesE E Cherullo, L E Ponsky, K K Goyal, et al.
International Journal of Impotence Research|November 5, 2004
Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysisR Raina, A Agarwal, Carlumandarlo E B Zaramo, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Urology|June 24, 1999
Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA statS Sharma, C D Zippe, L Pandrangi, et al.
BJU International|June 8, 2004
Bupivacaine provides rapid, effective periprostatic anaesthesia for transrectal prostate biopsyJ C Rabets, J S Jones, A R Patel, et al.
The Annals of Pharmacotherapy|January 7, 1998
Comment: clinical experiences of visual disturbances with nilutamideG A Dijkman, L H Klotz, A C Diokno, et al.
Urology|November 24, 1999
Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year resultsF M Jhaveri, C D Zippe, E A Klein, et al.
Urology|August 12, 1999
Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancerS Kedia, C D Zippe, A Agarwal, et al.
Urology|December 4, 1998
Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)C D Zippe, A W Kedia, K Kedia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cellsY Zhang, C D Zippe, F Van Lente, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?D Keyser, P A Kupelian, C D Zippe, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2004
Variable definitions influence the reporting of biochemical failure ratesE E Cherullo, L E Ponsky, K K Goyal, et al.
International Journal of Impotence Research|November 5, 2004
Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysisR Raina, A Agarwal, Carlumandarlo E B Zaramo, et al.
Pageof 4